The medicine Vidaza contains Azacitidine, a nucleoside metabolic inhibitor that is used in treating French-American-British (FAB) myelodysplastic syndrome subtypes: refractory anemia (RA), or refractory anemia with ringed sideroblasts, refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL). The medicine comes in single-use vials of 100 mg for subcutaneous and intravenous infusion. The active ingredient in the medicine is Azacitidine, with the inactive ingredient mannitol.
Azacitidine injection is readily available from several generic medicine suppliers. To know more about Azacitidine, contact us at 1800-889-1064.